• Guidance
  • Interesting shortcuts
  • EFFRA Members' Perspectives
  • News Dashboard
  • Structured Wiki
    • Search
    • FoF and Made in Europe Partnership
    • Demonstrators, pilots, prototypes
    • Exploitable result(s)
    • Significant innovations and lessons learned, training aspects
    • Report - Video - Presentation - Publication....?
    • Project clusters
    • EFFRA member perspectives
    • Manufacturing future products
    • Manufacturing performance characteristics
    • Technologies and enablers
    • ICT performance characteristics
    • Standards, technical committees and working groups
    • Contribution of R&I projects to standardisation
    • Regulatory and policy aspects
    • Standards - other classifications
    • Business model aspects
    • Pathways
    • MiE SRIA R&I Priorities
    • MiE WP26-27 Consultation - Potential Research Topics only
    • MiE WP26-27 Consultation and context pointers
    • MiE WP26-27 Consultation with pointers to WP25-27 consultation
    • MiE KPIs
    • Relevant (future) calls
    • EU-Programme-Call
    • NACE code
    • EFFRA Organisations - members
    • EFFRA WG pointers
  • Pathways
    • Pathways
  • Projects
    • Projects
  • Resources
    • Resources
  • Project ideas
    • Project ideas
  • People & organisations
    • People
    • Organisations
  • portal@effra.eu
  • Visit the EFFRA website
    • Login
  • Structured Wiki
  • EU-Programme-Call
  • Horizon Europe
  • HORIZON.2 Global Challenges and European Industrial Competitiveness
  • HORIZON.2.1 Health
  • HORIZON.2.1.0 Cross-cutting call topics

HORIZON.2.1.0 Cross-cutting call topics

  • HORIZON-HLTH-2022-DISEASE-06-two-stage
    • HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines
    • HORIZON-HLTH-2022-DISEASE-06-04-two-stage Development of new effective therapies for rare diseases
  • HORIZON-HLTH-2022-DISEASE-07
    • HORIZON-HLTH-2022-DISEASE-07-02 Pandemic preparedness
    • HORIZON-HLTH-2022-DISEASE-07-03 Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)
  • HORIZON-HLTH-2022-IND-13
    • HORIZON-HLTH-2022-IND-13-01 Enhancing cybersecurity of connected medical devices
    • HORIZON-HLTH-2022-IND-13-02 Scaling up multi-party computation, data anonymisation techniques, and synthetic data generation
  • HORIZON-HLTH-2022-STAYHLTH-01-two-stage
    • HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Prevention of obesity throughout the life course
  • HORIZON-HLTH-2022-TOOL-11
    • HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers
    • HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment
  • HORIZON-HLTH-2022-TOOL-12-two-stage
    • HORIZON-HLTH-2022-TOOL-12-01-two-stage Computational models for new patient stratification strategies
  • HORIZON-HLTH-2023-CARE-04
    • HORIZON-HLTH-2023-CARE-04-01 Maintaining access to regular health and care services in case of cross-border emergencies
    • HORIZON-HLTH-2023-CARE-04-02 Resilience and mental wellbeing of the health and care workforce
    • HORIZON-HLTH-2023-CARE-04-03 Environmentally sustainable and climate neutral health and care systems
  • HORIZON-HLTH-2023-CARE-08
    • HORIZON-HLTH-2023-CARE-08-01 European Partnership on Personalised Medicine
  • HORIZON-HLTH-2023-DISEASE-03
    • HORIZON-HLTH-2023-DISEASE-03-01 Novel approaches for palliative and end-of-life care for non-cancer patients
    • HORIZON-HLTH-2023-DISEASE-03-03 Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)
    • HORIZON-HLTH-2023-DISEASE-03-07 Relationship between infections and non-communicable diseases
  • HORIZON-HLTH-2023-ENVHLTH-02
    • HORIZON-HLTH-2023-ENVHLTH-02-01 Planetary health: understanding the links between environmental degradation and health impacts
    • HORIZON-HLTH-2023-ENVHLTH-02-02 Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)
  • HORIZON-HLTH-2023-IND-06
    • HORIZON-HLTH-2023-IND-06-01 Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU
    • HORIZON-HLTH-2023-IND-06-07 Development and harmonisation of methodologies for assessing digital health technologies in Europe
  • HORIZON-HLTH-2023-PSPA-10-IBA
    • HORIZON-HLTH-2023-PSPA-10-01-IBA Presidency event - Spain. Genomics-based health strategies: towards personalised and precision medicine
  • HORIZON-HLTH-2023-PSWE-09-IBA
    • HORIZON-HLTH-2023-PSWE-09-01-IBA Presidency event - Sweden. Life sciences: The era of precision medicine
  • HORIZON-HLTH-2023-STAYHLTH-01
    • HORIZON-HLTH-2023-STAYHLTH-01-01 The Silver Deal - Person-centred health and care in European regions
  • HORIZON-HLTH-2023-TOOL-05
    • HORIZON-HLTH-2023-TOOL-05-01 Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)
    • HORIZON-HLTH-2023-TOOL-05-03 Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management
    • HORIZON-HLTH-2023-TOOL-05-04 Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes
    • HORIZON-HLTH-2023-TOOL-05-05 Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery
    • HORIZON-HLTH-2023-TOOL-05-08 Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats
  • HORIZON-JU-GH-EDCTP3-2022-01
    • HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01 Promoting implementation of research results into policy and practice
    • HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02 Implementing adaptive platform trials
    • HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03 Genomic epidemiology for surveillance and control of poverty-related and emerging/re-emerging infections in sub-Saharan Africa
    • HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04 Creating a sustainable clinical trial network for infectious diseases in sub-Saharan Africa
    • HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05 Strengthening regulatory capacity for supporting conduct of clinical trials
  • HORIZON-JU-GH-EDCTP3-2022-01
    • HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01 Promoting implementation of research results into policy and practice
  • HORIZON-JU-GH-EDCTP3-2023-01
    • HORIZON-JU-GH-EDCTP3-2023-01-01 Global Health EDCTP3 Training Networks - Clinical Research Fellowships
    • HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic
    • HORIZON-JU-GH-EDCTP3-2023-01-03 Implementation research/real life assessment of existing interventions in women and children’s health
    • HORIZON-JU-GH-EDCTP3-2023-01-04 Research to rapidly evaluate interventions on Ebola outbreaks in sub-Saharan Africa
    • HORIZON-JU-GH-EDCTP3-2023-01-05 Strengthening ethics and regulatory capacity
  • HORIZON-JU-GH-EDCTP3-2024-Mpox Mobilisation of Emergency funding for Mpox outbreak research response
  • HORIZON-JU-IHI-2022-02-two-stage
    • HORIZON-JU-IHI-2022-02-02 Setting up a harmonised methodology to promote uptake of early feasibility studies for clinical and innovation excellence in the European Union
  • HORIZON-JU-IHI-2022-03-single-stage
    • HORIZON-JU-IHI-2022-03-01 Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
    • HORIZON-JU-IHI-2022-03-02 Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
  • HORIZON-MISS-2021-CANCER-02
    • HORIZON-MISS-2021-CANCER-02-01 Develop new methods and technologies for cancer screening and early detection
    • HORIZON-MISS-2021-CANCER-02-02 Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors
    • HORIZON-MISS-2021-CANCER-02-03 Better understanding of the impact of risk factors and health determinants on the development and progression of cancer
  • HORIZON-MISS-2021-UNCAN-01
    • HORIZON-MISS-2021-UNCAN-01-01 Preparing UNCAN.eu, a European initiative to understand cancer
  • HORIZON-MISS-2022-CANCER-01
    • HORIZON-MISS-2022-CANCER-01-01 Improving and upscaling primary prevention of cancer through implementation research
    • HORIZON-MISS-2022-CANCER-01-02 Strengthening research capacities of Comprehensive Cancer Infrastructures
    • HORIZON-MISS-2022-CANCER-01-03 Pragmatic clinical trials to optimise treatments for patients with refractory cancers
    • HORIZON-MISS-2022-CANCER-01-05 Establishing of national cancer mission hubs and creation of network to support the Mission on Cancer
  • HORIZON-MISS-2023-CANCER-01
    • HORIZON-MISS-2023-CANCER-01-01 Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.
    • HORIZON-MISS-2023-CANCER-01-02 Enhance primary cancer prevention through sustainable behavioural change
    • HORIZON-MISS-2023-CANCER-01-03 Pragmatic clinical trials on minimally invasive diagnostics
    • HORIZON-MISS-2023-CANCER-01-04 Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions
  • HORIZON-MISS-2023-CANCER-01
    • HORIZON-MISS-2023-CANCER-01-01 Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.
    • HORIZON-MISS-2023-CANCER-01-02 Enhance primary cancer prevention through sustainable behavioural change
    • HORIZON-MISS-2023-CANCER-01-03 Pragmatic clinical trials on minimally invasive diagnostics
Powered by Chris Decubber BV